Aurinia Pharmaceuticals Inc (AUPH)
7.18
-0.11
(-1.51%)
USD |
NASDAQ |
Oct 04, 16:00
7.18
0.00 (0.00%)
After-Hours: 16:48
Aurinia Pharmaceuticals PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| May 15, 2012 | 380.69 |
| May 07, 2012 | 489.04 |
| March 31, 2012 | |
| March 26, 2012 | |
| March 19, 2012 | |
| February 27, 2012 | |
| January 06, 2012 |
| Date | Value |
|---|---|
| December 31, 2011 | |
| November 02, 2011 | 417.73 |
| October 28, 2011 | 499.78 |
| October 27, 2011 | 499.78 |
| October 25, 2011 | 488.39 |
| October 20, 2011 | 478.62 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
PE Ratio Related Metrics
| PS Ratio | 6.384 |
| Price to Book Value | 2.625 |
| Price | 7.18 |
| Earnings Yield | -6.96% |
| Market Cap | 1.030B |